查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床前 CRO 市場——按服務（生物分析和 DMPK 試驗、毒理學試驗）、按最終用戶（生物製藥公司、政府和學術機構、醫療器械公司）、按地區和全球預測，2023-2032 年
市場調查報告書
商品編碼
1262674

臨床前 CRO 市場——按服務（生物分析和 DMPK 試驗、毒理學試驗）、按最終用戶（生物製藥公司、政府和學術機構、醫療器械公司）、按地區和全球預測，2023-2032 年

Preclinical CRO Market - By Service (Bioanalysis & DMPK Studies, Toxicology Testing), By End-use (Biopharmaceutical Companies, Government & Academic Institutes, Medical Device Companies), By Region & Global Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 104 Pages | 商品交期: 2-3個工作天內

價格

臨床前 CRO 市場將在 2032 年穩步增長，因為慢性病的增加和對有效治療的需求不斷增加預計會推動臨床前研究中藥物使用的增加。

此外，生物技術和製藥公司通常選擇外包來滿足他們在臨床前試驗中的醫療需求，從而加快整個過程。 為此，進入臨床前階段的藥物數量顯著增加。

總體而言，臨床前 CRO 市場在最終用途、服務和地域方面存在分歧。

在服務領域，“其他”子領域預計在估計期內將保持超過 7% 的複合年增長率的穩定增長率。 臨床前CRO市場的其他服務包括生物利用度研究、生物等效性研究、藥物相互作用研究服務等。

臨床前 CRO 市場根據最終用途細分為政府/學術機構、生物製藥公司、醫療設備公司等。 其中，政府和學術機構部門將在 2022 年佔據超過 14.5% 的市場份額。 這種增長主要歸因於委託給學術機構的研究和調查活動數量的增加。 學術機構和政府也正在提供臨床前診斷和治療的途徑，這將推動未來臨床前 CRO 行業的發展。

按地區劃分，臨床前 CRO 市場大致分為北美、歐洲、亞洲格局、市場格局和亞太地區。 其中，亞太地區臨床前CRO市場有望在預測期內實現穩定增長。 該地區老年人口的增加，糖尿病、癌症、心髒病等慢性病患病率的增加，預計將補充市場增長。

此外，亞太地區腫瘤領域的研究藥物和正在進行的臨床前試驗的數量正在增加，這有望推動該地區臨床前 CRO 業務的規模。

另一方面，拉美地區的臨床前 CRO 市場預計在分析期內也將出現強勁增長。 該地區擁有發達的醫療保健基礎設施和成熟的監管環境。 這些因素使拉丁美洲成為臨床前研究的沃土。

在臨床前 CRO 市場運營的領先公司包括：Laboratory Corporation of America Inc.、Charles River Laboratory Inc.、Pharmaceutical Product Development. (PPD) LLC、ICON plc、Eurofins Scientific、Parexel International Corporation, Medpace, WuXi AppTec, SGS SA, Altasciences Company, Inc.

目錄

第一章研究方法論

  • 調查方法
  • 市場範圍和定義
  • 基本估算
  • 預測計算
  • 關於 COVID-19 的全球影響
  • 數據驗證
  • 數據源
    • 二手數據
      • 付費資源
      • 無償來源
    • 主要數據

第 2 章執行摘要

第 3 章臨床前 CRO 行業洞察

  • 按行業細分
  • 行業格局，2018-2032 年版
  • 影響行業的因素
    • 司機
      • 全球研發支出增加
      • 擴大研發活動的外包
      • 臨床前研究中的藥物數量增加
    • 行業潛在的風險和挑戰
      • 嚴格的監管政策
  • 增長分析
    • 按服務
    • 按最終用途
  • COVID-19 影響分析
  • 臨床前研究的體積分析
    • 2018-2021 年按地區劃分的臨床前研究量分析
    • 臨床前研究量分析，按適應症分類，2018-2021 年
    • 臨床前研究量分析，按發展階段，2018-2021 年
  • 監管狀況
    • 美國
    • 歐洲
    • 亞太地區
      • 新加坡
      • 馬來西亞
      • 印度尼西亞
      • 泰國
      • 韓國
      • 菲律賓
  • 臨床試驗 - 亞太優勢
  • 價格/情況
  • 工業生態系統分析
  • 藥物發現和開發過程
  • 波特分析
  • PESTEL 分析

第 4 章競爭格局，2022 年

  • 介紹
  • 公司矩陣分析，2022 年
  • 公司股票分析，2022 年
  • 戰略儀錶盤，2022 年
  • 併購情況
    • CRO 行業的併購交易，2018-2022 年版
    • 完成合同研究所併購項目（2018-2021 年）
    • 私募股權對 CRO 併購的影響
      • PRA 健康科學
      • Medpace, Inc.
      • PPD
      • Parexel 國際公司
    • 行業重組對整體市場的影響
    • 分析師觀點

第 5 章臨床前 CRO 市場：按服務分類

  • 主要細分趨勢
  • 生物分析和 DMPK 研究
  • 毒理學測試
  • 其他

第 6 章臨床前 CRO 市場：按最終用途分類

  • 主要細分趨勢
  • 生物製藥公司
  • 政府機構、學術機構
  • 醫療設備製造商
  • 其他

第 7 章臨床前 CRO 設備市場：按地區

  • 主要區域趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • 多邊環境協定
    • 南非
    • 沙特阿拉伯

第八章公司簡介

  • Charles River Laboratory, Inc.
  • Laboratory Corporation of America, Inc.
  • Pharmaceutical Product Development（PPD）, LLC（a part of Thermo Fisher Scientific）,
  • ICON plc
  • Eurofins Scientific
  • Parexel International Corporation
  • Medpace, Inc.
  • WuXi AppTec
  • SGS SA
  • Altasciences Company, Inc.
Product Code: 2860

Preclinical CRO Market is slated to grow at a robust rate through 2032 owing to the increasing usage of drugs during preclinical trials given the rising cases of chronic diseases and an increasing demand for effective treatment for the same. Besides, various biotechnology and pharmaceutical companies, quite often, opt for outsourcing to attain the medical needs for preclinical validations to fasten up the whole process. This has significantly propelled the number of drugs entering the preclinical phase.

Overall, the preclinical CRO market has been bifurcated in terms of end-use, service, and region.

Within the service segment, the others subsegment is slated to grow at a steady rate of more than 7% CAGR through the estimated timeframe. The other services in the preclinical CRO market comprise bioavailability testing, bioequivalence testing, drug-interaction testing services, etc.

Based on end-use, the preclinical CRO market has been divided into government & academic institutes, biopharmaceutical companies, medical device companies, and others. Among them, the government & academic institutes segment held more than 14.5% market share in 2022. The growth can be primarily attributed to the increasing number of research and R&D activities that are outsourced to academic institutes. Besides, academic institutes and the governments are also providing diagnosis and access to treatments under preclinical trials, which is likely to propel the preclinical CRO industry growth in the upcoming time.

In the regional landscape, the preclinical CRO market has been broadly categorized into North America, Europe, LATAM, MEA, and Asia Pacific. Among them, the preclinical CRO market in the Asia Pacific region is anticipated to grow at a steady rate over the estimated timeframe. The increasing geriatric population in this region and rising cases of chronic diseases like diabetes, cancer, and cardiac diseases are anticipated to supplement the market growth.

Additionally, an increase in the number of investigational compounds and ongoing preclinical trials in oncology in Asia Pacific will boost the preclinical CRO business size in this region.

Meanwhile, the preclinical CRO market in the LATAM region is also slated to grow at a robust rate through the analysis timeframe. The healthcare infrastructure in this region is well-developed and it also boasts a well-established regulatory environment. These factors enable Latin America to be a fertile landscape to allow preclinical research to be conducted easily.

Some of the key companies operating in the preclinical CRO market are: Laboratory Corporation of America Inc., Charles River Laboratory Inc., Pharmaceutical Product Development (PPD) LLC, ICON plc, Eurofins Scientific, Parexel International Corporation, Medpace, Inc., WuXi AppTec, SGS SA, Altasciences Company, Inc.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market scope and definition
  • 1.3 Base estimates
  • 1.4 Forecast calculations
  • 1.5 COVID-19 impact at global level
  • 1.6 Data validation
  • 1.7 Data Sources
    • 1.7.1 Secondary
      • 1.7.1.1 Paid sources
      • 1.7.1.2 Unpaid sources
    • 1.7.2 Primary

Chapter 2 Executive Summary

  • 2.1 Preclinical CRO industry 360 degree synopsis, 2018 - 2032
    • 2.1.1 Business trends
    • 2.1.2 Service trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Preclinical CRO Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018 - 2032
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing R&D expenditure worldwide
      • 3.3.1.2 Growing outsourcing of R&D activities
      • 3.3.1.3 Rising number of drugs in preclinical trails
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Stringent regulatory policies
  • 3.4 Growth potential analysis
    • 3.4.1 By service
    • 3.4.2 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Preclinical trial volume analysis
    • 3.6.1 preclinical trial volume analysis, by region, 2018 - 2021
    • 3.6.2 preclinical trial volume analysis, by indication, 2018 - 2021
    • 3.6.3 preclinical trial volume analysis, by phase of development, 2018 - 2021
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
    • 3.7.3 Asia Pacific
      • 3.7.3.1 Singapore
      • 3.7.3.2 Malaysia
      • 3.7.3.3 Indonesia
      • 3.7.3.4 Thailand
      • 3.7.3.5 South Korea
      • 3.7.3.6 Philippines
  • 3.8 Clinical trials- Asia Pacific advantage
  • 3.9 Pricing Landscape
  • 3.10 Industry ecosystem analysis
  • 3.11 Drug discovery and development process
  • 3.12 Porter's analysis
  • 3.13 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Strategic dashboard, 2022
  • 4.5 Merger & acquisition landscape
    • 4.5.1 Merger & acquisition deals in the CRO industry, 2018 - 2022
    • 4.5.2 Completed contract research organization merger & acquisition deals, 2018-2021
    • 4.5.3 Influence of private equity in CRO mergers & acquisitions
      • 4.5.3.1 PRA Health Sciences
      • 4.5.3.2 Medpace, Inc.
      • 4.5.3.3 PPD, Inc.
      • 4.5.3.4 Parexel International Corporation
    • 4.5.4 Impact of industry consolidation on the overall market
    • 4.5.5 Analyst insights

Chapter 5 Preclinical CRO Market, By Service

  • 5.1 Key segment trends
  • 5.2 Bioanalysis & DMPK studies
    • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3 Toxicology testing
    • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.4 Others
    • 5.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Preclinical CRO Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Biopharmaceutical companies
    • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.3 Government and academic institutes
    • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.4 Medical devices companies
    • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 6.5 Others
    • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Preclinical CRO Devices Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
  • 7.6 MEA
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia

Chapter 8 Company Profiles

  • 8.1 Charles River Laboratory, Inc.
  • 8.2 Laboratory Corporation of America, Inc.
  • 8.3 Pharmaceutical Product Development (PPD), LLC (a part of Thermo Fisher Scientific),
  • 8.4 ICON plc
  • 8.5 Eurofins Scientific
  • 8.6 Parexel International Corporation
  • 8.7 Medpace, Inc.
  • 8.8 WuXi AppTec
  • 8.9 SGS SA
  • 8.10 Altasciences Company, Inc.

Data Tables

  • TABLE 1. Global preclinical CRO market, 2018 - 2022 (USD Million)
  • TABLE 2. Global preclinical CRO market, 2023 - 2032 (USD Million)
  • TABLE 3. Global preclinical CRO market, by service, 2018 - 2022 (USD Million)
  • TABLE 4. Global preclinical CRO market, by service, 2023 - 2032 (USD Million)
  • TABLE 5. Global preclinical CRO market, by end-use, 2018 - 2022 (USD Million)
  • TABLE 6. Global preclinical CRO market, by end-use, 2023 - 2032 (USD Million)
  • TABLE 7. Global preclinical CRO market, by region, 2018 - 2022 (USD Million)
  • TABLE 8. Global preclinical CRO market, by region, 2023 - 2032 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Mergers and acquisitions landscape, 2018 - 2022
  • TABLE 11. Bioanalysis & DMPK studies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 12. Bioanalysis & DMPK studies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 13. Toxicology testing market size, by region, 2018 - 2022 (USD Million)
  • TABLE 14. Toxicology testing market size, by region, 2023 - 2032 (USD Million)
  • TABLE 15. Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 16. Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 17. Biopharmaceutical companies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 18. Biopharmaceutical companies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 19. Government & academic institutes market size, by region, 2018 - 2022 (USD Million)
  • TABLE 20. Government & academic institutes market size, by region, 2023 - 2032 (USD Million)
  • TABLE 21. Medical device companies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22. Medical device companies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23. Others market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24. Others market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25. North America preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 26. North America preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 27. North America preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 28. North America preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 29. North America preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 30. North America preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 31. U.S. preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 32. U.S. preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 33. U.S. preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 34. U.S. preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 35. Canada preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 36. Canada preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 37. Canada preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 38. Canada preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 39. Europe preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 40. Europe preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 41. Europe preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 42. Europe preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 43. Europe preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 44. Europe preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 45. Germany preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 46. Germany preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 47. Germany preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 48. Germany preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 49. UK preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 50. UK preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 51. UK preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 52. UK preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 53. France preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 54. France preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 55. France preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 56. France preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 57. Italy preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 58. Italy preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 59. Italy preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 60. Italy preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 61. Spain preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 62. Spain preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 63. Spain preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 64. Spain preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 65. Asia Pacific preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 66. Asia Pacific preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 67. Asia Pacific preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 68. Asia Pacific preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 69. Asia Pacific preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 70. Asia Pacific preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 71. Japan preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 72. Japan preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 73. Japan preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 74. Japan preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 75. China preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 76. China preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 77. China preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 78. China preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 79. India preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 80. India preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 81. India preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 82. India preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 83. Australia preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 84. Australia preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 85. Australia preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 86. Australia preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 87. Latin America preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 88. Latin America preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 89. Latin America preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 90. Latin America preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 91. Latin America preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 92. Latin America preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 93. Brazil preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 94. Brazil preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 95. Brazil preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 96. Brazil preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 97. Mexico preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 98. Mexico preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 99. Mexico preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 100. Mexico preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 101. MEA preclinical CRO market size, by country, 2018 - 2022 (USD Million)
  • TABLE 102. MEA preclinical CRO market size, by country, 2023 - 2032 (USD Million)
  • TABLE 103. MEA preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 104. MEA preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 105. MEA preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 106. MEA preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 107. South Africa preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 108. South Africa preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 109. South Africa preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 110. South Africa preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)
  • TABLE 111. Saudi Arabia preclinical CRO market size, by service, 2018 - 2022 (USD Million)
  • TABLE 112. Saudi Arabia preclinical CRO market size, by service, 2023 - 2032 (USD Million)
  • TABLE 113. Saudi Arabia preclinical CRO market size, by end-use, 2018 - 2022 (USD Million)
  • TABLE 114. Saudi Arabia preclinical CRO market size, by end-use, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1. Top-down approach
  • FIG 2. Breakdown of primary participants
  • FIG 3. Preclinical industry 360 degree synopsis, 2018 - 2032
  • FIG 4. Industry segmentation
  • FIG 5. Industry landscape, 2018-2032 (USD Million)
  • FIG 6. Growth potential analysis, by service
  • FIG 7. Growth potential analysis, by end-use
  • FIG 8. Industry ecosystem analysis
  • FIG 9. Drug discovery and development process
  • FIG 10. Company matrix analysis, 2022
  • FIG 11. Strategy dashboard, 2022
  • FIG 12. Key segment trends, by service
  • FIG 13. Key segment trends, by end-use
  • FIG 14. Key regional trends